This cluster is too small relative to market cap to carry a directional signal. The CCO's sales are tied to option exercises (routine liquidity), and director sales are modest. Monitor for any upcoming earnings or clinical data readouts that could drive the stock, but this insider activity alone does not warrant action.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 12 $165.11entry
- T+1 · 3mo ago −3.37%α −4.07% · $159.54
- T+5 · 3mo ago −1.07%α −0.63% · $163.34
- T+20 · 2mo ago −3.68%α −1.78% · $159.03
- T+60 · 12d ago +2.10%α +6.98% · $168.58
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three Guardant Health insiders, including the Chief Commercial Officer and two directors, sold a total of $2.84M in stock over a week. The CCO's sales were part of a larger option exercise-and-sell pattern, while the directors' sales were smaller open-market transactions. The total dollar value is only ~0.01% of the $22.2B market cap, making this a trivial cluster with no material signal.
Key Financial Metrics
Key Facts
- Three insiders sold shares totaling $2.84M over a 7-day window
- CCO Chris Freeman sold $1.24M in open-market sales alongside derivative exercises
- Two directors sold smaller amounts: Ian Clark ($1.44M) and Manuel Hidalgo Medina ($156K)
- Total insider sales represent ~0.01% of GH's $22.2B market cap
- Two CEOs made non-cash gifts of 110,000 shares combined during the same period
Financial Impact
Total insider sales of $2.84M represent ~0.01% of market cap, trivial
Risk Factors
- No material insider signal, cluster is noise relative to $22.2B market cap
- CCO's sales are part of a standard exercise-and-sell pattern, not a conviction sale
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GH-1786573242705 |
Track record
38 reports on GH
3 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +22.49% at T+60 after the May 27, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $145.04 Now $144.03 −0.70% settles Dec 16
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $150.87 Now $144.03 −4.53% settles Dec 7
- Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $153.43 Now $144.03 −6.13% settles Dec 4
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $168.58 Now $144.03 −14.56% settles Dec 3
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $175.00 Now $144.03 −17.70% settles Dec 2
- Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $162.94 Now $144.03 −11.61% settles Nov 19
- Oct 14, 20264w ago 144 Neutral 2/10 Entry $165.88 to $154.86 Now $144.03 −13.17% ▼ −6.64% −4.74% vs SPY
- Sep 17, 20268w ago Insider Cluster Bearish 5/10 Entry $179.38 to $158.60 Now $144.03 +19.71% ▲ +11.58% +11.79% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers